Can a wrong word in Drug Facts Uses or Purpose mislead a buyer?

Yes. 21 CFR 201.66 says Purpose gives the general pharmacological category or principal intended action of each active ingredient, and Uses gives the indications for the specific product. Our view: a correctly spelled wrong word in either line can tell a buyer the product treats something it doesn't, or does something it doesn't. Spellcheck passes it.

This page is general information, not legal or regulatory advice.

For the Drug Facts panel alongside the other sections, see how to proofread a drug label for meaning, section by section. This page covers the Purpose and Uses lines.

What Purpose and Uses must show

• Purpose. 21 CFR 201.66 says the Purpose heading is followed by the general pharmacological category or principal intended action of the drug, or of each active ingredient when there's more than one. When an OTC monograph has a statement of identity, the action it describes must also be stated as the purpose.
• Uses. 21 CFR 201.66 says the Use or Uses heading is followed by the indications for the specific product. The FDA's consumer page describes Uses as the symptoms or diseases the product will treat or prevent.

The words that carry the claim

Our view: a Purpose line is often one or two words per active ingredient, and a Uses line is a short list of symptoms with a qualifier in front. The words that carry the claim are:

• The action or category word in Purpose.
• The symptom or condition words in Uses.
• The qualifiers that limit the claim, such as a word that says relief is temporary.

Each has fluent alternatives. A swapped symptom word claims a different use; a dropped qualifier claims more than the product does.

Monograph wording vs the artwork

Our view: because much of this wording is set by a monograph, it can look safe to skip. But the monograph is the source, not the printed panel, and a swap can get in at any step between them. For when required monograph wording is missing altogether, see missing required words in Drug Facts. For the fixed headings and the terms a firm may swap, see drug label wording rules.

Matching the rest of the label

Practice advice:

• Check that each Purpose line matches the statement of identity, as 21 CFR 201.66 asks when a monograph sets one. The statement of identity belongs on the principal display panel under 21 CFR 201.61, while Drug Facts has its own placement rules in 21 CFR 201.66, so the two usually sit on different parts of the package. Read them side by side.
• Read the Uses line against its source monograph or approved labeling, word for word.
• Check that the Warnings and Directions fit the uses claimed. See wrong words in Drug Facts Warnings and wrong words in Drug Facts Directions.
• Read each use aloud as a promise to the buyer. If the promise changed, a word did.

This is our reading of public guidance, not legal or regulatory advice.

Sources

• eCFR: 21 CFR 201.66
• eCFR: 21 CFR 201.61
• FDA: The Over-the-Counter Drug Facts Label

Last reviewed: October 18, 2026

More on contextual errors in FDA DailyMed labels.

Questions about wording on your own labels? Talk to us.

We scan freshly published FDA DailyMed labels every day and pull out these high-stakes wrong words.

Every Tuesday and Friday, a new case like this lands in your inbox if you subscribe.

What's in Drug Facts Uses and Purpose?

Under 21 CFR 201.66, Purpose gives the category or principal intended action of each active ingredient, and Uses gives the indications for the specific product.

Can a wrong word here mislead buyers?

Yes. A swapped symptom word can claim a use the product doesn't have, and a dropped qualifier can claim more than it does.

Does monograph wording prevent errors?

Not on its own. The monograph is the source, not the printed panel, and a correctly spelled swap can get in between them.

How do I proofread Uses and Purpose for meaning?

Practice advice: match each Purpose line to the statement of identity, read Uses against its source word for word, and read each use aloud as a promise to the buyer.